[1]
G. L. Palhares, J. K. Lacourt, M. T. Silva, L. D. Coppola, M. E. O. C. Neves, and J. de S. P. Barbosa, “SAFETY PROFILE AND ADVERSE EVENTS ASSOCIATED WITH GLP-1/GIP RECEPTOR AGONISTS IN NON-DIABETIC INDIVIDUALS WITH OVERWEIGHT OR OBESITY: AN INTEGRATIVE REVIEW”, REASE, vol. 12, no. 8, Aug. 2026, doi: 10.51891/rease.v12i8.28288.